Upregulation of the Cav 1.1-ryanodine receptor complex in a rat model of critical illness myopathy

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 6, 2011, Pages 1384-1391

  Kraner, Susan D ^a   Wang, Qingbo ^a   Novak, Kevin R ^a   Cheng, Dongmei ^b   Cool, David R ^a   Peng, Junmin ^b   Rich, Mark M ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain; Muscular diseases; Myosins; Ryanodine receptor calcium release channel

Indexed keywords

ACTIN; CALCIUM; DEXAMETHASONE; FODRIN; MYOSIN; MYOSIN HEAVY CHAIN; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; VOLTAGE GATED CALCIUM CHANNEL; CAV PROTEIN, RAT; CAVEOLIN 1; KCNMA1 PROTEIN, RAT; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; RYANODINE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CRITICAL ILLNESS; FEMALE; IMMUNOHISTOCHEMISTRY; MUSCLE ATROPHY; MYOPATHY; NERVE LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SARCOMERE; SARCOPLASMIC RETICULUM; SCIATIC NERVE; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DENERVATION; DISEASE MODEL; METABOLISM; MUSCLE DISEASE; PHYSIOLOGY; UPREGULATION; WISTAR RAT;

ANIMALS; CALCIUM; CAVEOLIN 1; CRITICAL ILLNESS; DENERVATION; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MUSCULAR ATROPHY; MUSCULAR DISEASES; MYOSINS; RATS; RATS, WISTAR; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SCIATIC NERVE; UP-REGULATION;

EID: 79958789673     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00032.2011     Document Type: Article

References (68)

1. Aracena-Parks P, Goonasekera SA, Gilman CP, Dirksen RT, Hidalgo C, Hamilton SL. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem 281: 40354-40368, 2006.
2. Argadine HM, Hellyer NJ, Mantilla CB, Zhan WZ, Sieck GC. The effect of denervation on protein synthesis and degradation in adult rat diaphragm muscle. J Appl Physiol 107: 438-444, 2009.
3. Argadine HM, Mantilla CB, Zhan WZ, Sieck GC. Intracellular signaling pathways regulating net protein balance following diaphragm muscle denervation. Am J Physiol Cell Physiol 300: C318-C327, 2011.
4. 2+ channel. J Gen Physiol 115: 467-480, 2000.
5. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 15: 325-330, 2009.
6. Berg DK, Hall ZW. Increased extrajunctional acetylcholine sensitivity produced by chronic post-synaptic neuromuscular blockade. J Physiol 244: 659-676, 1975.
7. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valen-zuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
8. Campellone JV, Lacomis D, Kramer DJ, Van Cott AC, Giuliani MJ. Acute myopathy after liver transplantation. Neurology 50: 46-53, 1998.
9. 2+-dependent proteolysis in muscle wasting. Int J Biochem Cell Biol 37: 2134-2146, 2005.
10. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14: 1131-1139, 1991.
11. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288: 2859-2867, 2002.
12. Di Biase V, Franzini-Armstrong C. Evolution of skeletal type e-c coupling: a novel means of controlling calcium delivery. J Cell Biol 171: 695-704, 2005.
13. Di Giovanni S, Mirabella M, D'Amico A, Tonali P, Servidei S. Apoptotic features accompany acute quadriplegic myopathy. Neurology 55: 854-858, 2000.
14. Favier FB, Benoit H, Freyssenet D. Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflügers Arch 456: 587-600, 2008.
15. Geiger PC, Bailey JP, Zhan WZ, Mantilla CB, Sieck GC. Denervation-induced changes in myosin heavy chain expression in the rat diaphragm muscle. J Appl Physiol 95: 611-619, 2003.
16. Geiger PC, Cody MJ, Macken RL, Bayrd ME, Sieck GC. Effect of unilateral denervation on maximum specific force in rat diaphragm muscle fibers. J Appl Physiol 90: 1196-1204, 2001.
17. Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D, Ketelslegers JM, Thissen JP. Myostatin gene deletion prevents gluco-corticoid-induced muscle atrophy. Endocrinology 148: 452-460, 2007.
18. Helliwell TR, Coakley JH, Wagenmakers AJ, Griffiths RD, Campbell IT, Green CJ, McClelland P, Bone JM. Necrotizing myopathy in critically-ill patients. J Pathol 164: 307-314, 1991.
19. Hellyer NJ, Mantilla CB, Park EW, Zhan WZ, Sieck GC. Neuregulin-dependent protein synthesis in C2C12 myotubes and rat diaphragm muscle. Am J Physiol Cell Physiol 291: C1056-C1061, 2006.
20. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348: 683-693, 2003.
21. 2+ uptake capacity of sarcoplasmic reticulum. J Appl Physiol 82: 164-171, 1997.
22. Hudson LD, Lee CM. Neuromuscular sequelae of critical illness. N Engl J Med 348: 745-747, 2003.
23. Itagaki K, Menconi M, Antoniu B, Zhang Q, Gonnella P, Soybel DI, Hauser CJ, Hasselgren PO. Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A2 -dependent mechanism. Am J Physiol Cell Physiol 298: C1127-C1139, 2010.
24. 2+ channel is expressed in sarcolemma of type I and IIa myofibers of adult skeletal muscle. Muscle Nerve 36: 482-490, 2007.
25. Khan J, Harrison TB, Rich MM, Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67: 1421-1425, 2006.
26. Kraner S, Yang J, Barchi R. Structural inferences for the native skeletal muscle sodium channel as derived from patterns of endogenous proteolysis. J Biol Chem 264: 13273-13280, 1989.
27. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene-a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59: 364-373, 2004.
28. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40: 645-654, 1996.
29. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 23: 1785-1788, 2000.
30. Larsson L. Acute quadriplegic myopathy: an acquired "myosinopathy". Adv Exp Med Biol 642: 92-98, 2008.
31. Larsson L, Li X, Edstrom L, Eriksson LI, Zackrisson H, Argentini C, Schiaffino S. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 28: 34-45, 2000.
32. Lehnart SE, Wehrens XH, Marks AR. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochem Biophys Res Commun 322: 1267-1279, 2004.
33. Lewis MI, Monn SA, Sieck GC. Effect of corticosteroids on diaphragm fatigue, SDH activity, and muscle fiber size. J Appl Physiol 72: 293-301, 1992.
34. Lomo T, Rosenthal J. Control of ACh sensitivity by muscle activity in the rat. J Physiol 221: 493-513, 1972.
35. Lomo T, Westgaard RH. Further studies on the control of ACh sensitivity by muscle activity in the rat. J Physiol 252: 603-626, 1975.
36. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmati-cus. Lancet 2: 615, 1977.
37. Marks AR. Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol Heart Circ Physiol 272: H597-H605, 1997.
38. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 15: 1290-1298, 1992.
39. Moore BJ, Miller MJ, Feldman HA, Reid MB. Diaphragm atrophy and weakness in cortisone-treated rats. J Appl Physiol 67: 2420-2426, 1989.
40. Mozaffar T, Haddad F, Zeng M, Zhang LY, Adams GR, Baldwin KM. Molecular and cellular defects of skeletal muscle in an animal model of acute quadriplegic myopathy. Muscle Nerve 35: 55-65, 2007.
41. Nakai J, Dirksen RT, Nguyen HT, Pessah IN, Beam KG, Allen PD. Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature 380: 72-75, 1996.
42. Norman H, Nordquist J, Andersson P, Ansved T, Tang X, Dworkin B, Larsson L. Impact of post-synaptic block of neuromuscular transmission, muscle unloading and mechanical ventilation on skeletal muscle protein and mRNA expression. Pflügers Arch 453: 53-66, 2006.
43. Norman H, Zackrisson H, Hedstrom Y, Andersson P, Nordquist J, Eriksson LI, Libelius R, Larsson L. Myofibrillar protein and gene expression in acute quadriplegic myopathy. J Neurol Sci 285: 28-38, 2009.
44. 2+ activation of force generation in single human skeletal muscle fibres. Exp Physiol 93: 486-495, 2008.
45. Polla B, Bottinelli R, Sandoli D, Sardi C, Reggiani C. Cortisone-induced changes in myosin heavy chain distribution in respiratory and hindlimb muscles. Acta Physiol Scand 151: 353-361, 1994.
46. Rich MM, Bird SJ, Raps EC, McCluskey LF, Teener JW. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20: 665-673, 1997.
47. Rich MM, Kraner SD, Barchi RL. Altered gene expression in steroid-treated denervated muscle. Neurobiol Dis 6: 515-522, 1999.
48. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 43: 171-179, 1998.
49. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 46: 731-736, 1996.
50. Rouleau G, Karpati G, Carpenter S, Soza M, Prescott S, Holland P. Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 10: 428-438, 1987.
51. Sakai Y, Kobayashi K, Iwata N. Effects of an anabolic steroid and vitamin B complex upon myopathy induced by corticosteroids. Eur J Pharmacol 52: 353-359, 1978.
52. Showalter CJ, Engel AG. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 20: 316-322, 1997.
53. Stibler H, Edstrom L, Ahlbeck K, Remahl S, Ansved T. Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 29: 1515-1527, 2003.
54. 3H]azidopine within the alpha 1 subunit. Proc Natl Acad Sci USA 88: 10769-10773, 1991.
55. Sultan KR, Dittrich BT, Leisner E, Paul N, Pette D. Fiber type-specific expression of major proteolytic systems in fast- to slow-transforming rabbit muscle. Am J Physiol Cell Physiol 280: C239-C247, 2001.
56. Sun J, Xin C, Eu JP, Stamler JS, Meissner G. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci USA 98: 11158-11162, 2001.
57. Supinski GS, Callahan LA. Calpain activation contributes to endotoxin induced diaphragmatic dysfunction. Am J Respir Cell Mol Biol 42: 80-87, 2009.
58. Supinski GS, Wang W, Callahan LA. Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol 107: 1389-1396, 2009.
59. Van Balkom RH, Zhan WZ, Prakash YS, Dekhuijzen PN, Sieck GC. Corticosteroid effects on isotonic contractile properties of rat diaphragm muscle. J Appl Physiol 83: 1062-1067, 1997.
60. Verheul AJ, Mantilla CB, Zhan WZ, Bernal M, Dekhuijzen PN, Sieck GC. Influence of corticosteroids on myonuclear domain size in the rat diaphragm muscle. J Appl Physiol 97: 1715-1722, 2004.
61. Wang KK. Calpain and caspase: can you tell the difference?, by Kevin K. W. Wang: Vol. 23, p. 20-26. Trends Neurosci 23: 59, 2000.
62. Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM. Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. J Neurosci 25: 343-351, 2005.
63. Wehrens XH, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci USA 102: 9607-9612, 2005.
64. Williams AB, Decourten-Myers GM, Fischer JE, Luo G, Sun X, Hasselgren PO. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 13: 1435-1443, 1999.
65. Winiarski AM, Roy RR, Alford EK, Chiang PC, Edgerton VR. Mechanical properties of rat skeletal muscle after hind limb suspension. Exp Neurol 96: 650-660, 1987.
66. Wray CJ, Sun X, Gang GI, Hasselgren PO. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle. J Surg Res 104: 82-87, 2002.
67. Zhan WZ, Sieck GC. Adaptations of diaphragm and medial gastrocnemius muscles to inactivity. J Appl Physiol 72: 1445-1453, 1992.
68. 2+ sparks in skeletal muscle fibers. J Pharmacol Exp Ther 314: 94-102, 2005.